Jakob Dupont
Directeur/Bestuurslid bij IMUGENE LIMITED
Vermogen: 167 114 $ op 31-05-2024
Profiel
Jakob Dupont is currently a Non-Executive Director at Imugene Ltd., a Director at Apexigen America, Inc., an Independent Director at Pyxis Oncology, Inc., an Executive Partner at Sofinnova Investments, Inc., and an Advisor at Ambrx, Inc. Previously, he worked as a Global Director-Medical at Genentech, Inc. from 2006 to 2011, an Independent Director at Apexigen, Inc. from 2020 to 2023, the VP & Global Head-Gynecologic Cancer Development at Genentech, Inc. from 2017 to 2018, the Chief Medical Officer & Senior Vice President at Mereo BioPharma 5, Inc. from 2011 to 2017, and the Chief Medical Officer at Gossamer Bio, Inc. from 2018 to 2020.
Dr. Dupont's education includes a graduate degree from New York University in 1991, an undergraduate degree from Vassar College in 1987, and a doctorate degree from Weill Cornell Medical College in 1996.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 02-03-2023 | 290 794 ( 0.24% ) | 163 135 $ | 31-05-2024 | |
IMUGENE LTD
0.00% | 12-01-2024 | 89 286 ( 0.00% ) | 3 979 $ | 31-05-2024 |
PYXIS ONCOLOGY, INC.
-.--% | 18-04-2024 | 0 ( -.--% ) | - $ | 31-05-2024 |
Actieve functies van Jakob Dupont
| Bedrijven | Functie | Begin |
|---|---|---|
| IMUGENE LIMITED | Directeur/Bestuurslid | 07-09-2022 |
| AMBRX INC | Consultant / Adviseur | 01-03-2021 |
| PYXIS ONCOLOGY, INC. | Directeur/Bestuurslid | 23-08-2023 |
Apexigen America, Inc.
 Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Apexigen America, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. Its product portfolio includes humanized antibodies, targeting diseases such as cancer, inflammatory diseases and ophthalmic disease. The company was founded by Xiao Dong Yang in July 2010 and is headquartered in San Carlos, CA. | Directeur/Bestuurslid | 19-08-2020 |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Private Equity Investor | 01-05-2023 |
Eerdere bekende functies van Jakob Dupont
| Bedrijven | Functie | Einde |
|---|---|---|
| APEXIGEN, INC. | Directeur/Bestuurslid | 23-08-2023 |
| ATARA BIOTHERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 12-05-2023 |
| GOSSAMER BIO, INC. | Hoofd Techniek/Wetenschap/O&O | 01-05-2020 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01-12-2018 |
| ░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Opleiding van Jakob Dupont
| Vassar College | Undergraduate Degree |
| New York University | Graduate Degree |
| Weill Cornell Medical College | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 5 |
|---|---|
| GOSSAMER BIO, INC. | Health Technology |
| ATARA BIOTHERAPEUTICS, INC. | Health Technology |
| APEXIGEN, INC. | Health Technology |
| IMUGENE LIMITED | Health Technology |
| PYXIS ONCOLOGY, INC. | Health Technology |
| Bedrijven in privébezit | 6 |
|---|---|
OncoMed Pharmaceuticals, Inc.
 OncoMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoMed Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on discovering and developing novel therapeutics for cancer's growth, resistance, recurrence and metastasis. The company was founded by Michael F. Clarke and Max Wicha in August 2004 and is headquartered in Redwood City, CA. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Memorial Sloan Kettering Cancer Center
 Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Memorial Sloan-Kettering Cancer Center operates as a private cancer center. It offers cancer care services to adult; and child and teen patients. Its services include risk assessment and screening; diagnosis and treatment; clinical trials; patient and caregiver education; and pediatric clinical trials. The company was founded by John J. Astor and Charlotte Astor in 1884 and is headquartered in New York, NY. | Health Services |
Apexigen America, Inc.
Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Apexigen America, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. Its product portfolio includes humanized antibodies, targeting diseases such as cancer, inflammatory diseases and ophthalmic disease. The company was founded by Xiao Dong Yang in July 2010 and is headquartered in San Carlos, CA. | Health Technology |
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Finance |
Ambrx, Inc.
 Ambrx, Inc. Pharmaceuticals: MajorHealth Technology Ambrx, Inc. engages in discovering and developing of protein therapeutics. It offers non-native amino acids through expanded genetic code to both generate novel bio-therapeutics. The company was founded by Richard DiMarchi, Peter G. Schultz, and Troy E. Wilson on April 15, 2003 and is headquartered in La Jolla, CA. | Health Technology |
